Clinical Trials Browser

Phase 2/3 × Injections × Gynecologic × Clear all

NCT06123884 2025-02-10

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms